Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BENDAMUSTINE for Mantle cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,227 adverse event reports in the FDA FAERS database where BENDAMUSTINE was used for Mantle cell lymphoma.

Most Reported Side Effects for BENDAMUSTINE

Side Effect Reports % Deaths Hosp.
Off label use 2,578 13.1% 532 730
Disease progression 2,456 12.5% 587 332
Pyrexia 1,322 6.7% 193 875
Neutropenia 1,256 6.4% 249 444
Drug ineffective 1,135 5.8% 290 302
Febrile neutropenia 1,005 5.1% 228 627
Pneumonia 975 5.0% 384 623
Thrombocytopenia 967 4.9% 214 351
Covid-19 892 4.5% 268 421
Anaemia 817 4.2% 186 328
Death 800 4.1% 800 151
Product use in unapproved indication 715 3.6% 189 264
Malignant neoplasm progression 664 3.4% 221 153
Pancytopenia 605 3.1% 187 284
Diarrhoea 588 3.0% 118 322

Other Indications for BENDAMUSTINE

Diffuse large b-cell lymphoma (3,538) Chronic lymphocytic leukaemia (2,561) Product used for unknown indication (1,678) B-cell lymphoma (1,668) Follicular lymphoma (1,560) Non-hodgkin's lymphoma (987) Plasma cell myeloma (945) Hodgkin's disease (676) Lymphoma (612) Waldenstrom's macroglobulinaemia (398)

Other Drugs Used for Mantle cell lymphoma

IBRUTINIB (6,306) RITUXIMAB (3,940) LENALIDOMIDE (2,989) CYCLOPHOSPHAMIDE (1,815) DOXORUBICIN (1,396) VENETOCLAX (1,367) VINCRISTINE (1,361) CYTARABINE (1,174) DEXAMETHASONE (949) PREDNISONE (852)

Related Pages

BENDAMUSTINE Full Profile All Mantle cell lymphoma Drugs BENDAMUSTINE Demographics BENDAMUSTINE Timeline